The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Laser Treatment

Robert Gallino, MD

September 2006—Using the Spectranetics Turbo catheter to treat a calcified lesion and a thrombotic occlusion in the SFA

Embolic Protection in Femoropopliteal Artery Intervention

Hank J. Freeman, MD, and John H. Rundback, MD

October 2006—What devices are available and when is it necessary?

Stenting of an Occlusive Femoral Artery Plaque Embolus

George Gordon Hartnell, FRCR, FACC

November 2006—A case report detailing the treatment of an uncommon complication.

Applying What We Know About Stent Fractures

David E. Allie, MD

November 2006—A summary of our clinical experience observing the incidence and impact of stent fractures.

Are Stent Fractures Significant?

Gary M. Ansel, MD

November 2006—Before condemning–or even categorizing–the technology as a whole, we need to pinpoint the true factors that impact outcome.

Establishing a Peripheral Vascular Center of Excellence

David E. Allie, MD; Chris J. Hebert, RT, R-CIS; and Craig M. Walker, MD

February 2005—It’s much more than just technology.

Do the TASC Guidelines Still Apply?

Dierk Scheinert, MD

May 2005—Current available data suggest that an adjustment may be necessary.

The Unconquered Ordeal

Takao Ohki, MD, PhD, Chief Medical Editor, Endovascular Today

June 2005—Why does this vessel continue to elude long-term success, and which technique, if any, will ultimately solve this problem?

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.